{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35643629", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "08"}, "DateRevised": {"Year": "2023", "Month": "07", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bpj.2022.05.038", "S0006-3495(22)00431-3"], "Journal": {"ISSN": "1542-0086", "JournalIssue": {"Volume": "121", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jul", "Day": "05"}}, "Title": "Biophysical journal", "ISOAbbreviation": "Biophys J"}, "ArticleTitle": "The SGYS motif of TAF15 prion-like domain is\u00a0critical to amyloid fibril formation.", "Pagination": {"StartPage": "2613", "EndPage": "2623", "MedlinePgn": "2613-2623"}, "Abstract": {"AbstractText": ["Misfolding of TATA-box binding protein-associated factor 15 (TAF15) may cause neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). Some mutations of prion-like domain (PrLD) have been detected in patients with sporadic ALS, suggesting the importance of TAF15-PrLD in ALS pathogenesis. Herein, combining experiments and molecular dynamics (MD) simulations, we investigated the influences of several TAF15-PrLD mutations on the amyloid fibril formation of TAF15-PrLD-extracted peptide segments, and identified an essential \u03b2-amyloid-forming segment from TAF15-PrLD. A pathogenic mutation T2 E71G resulted in significantly enhanced aggregation of the TAF15-PrLD segment T2 (Y<sup>56</sup>GQSQSGYSQSYGGYENQ<sup>73</sup>). In addition, the peptide T2 with a strong \u03b2-amyloid-forming tendency was able to induce the liquid to solid phase transition of TAF15-PrLD protein. Further study identified the SGYS motif as a critical segment that promoted the formation of amyloid fibrils, which maintained a stable \u03b2-sheet structure through intermolecular hydrogen bonds and \u03c0-\u03c0 stacking interaction. This work provides a clue to elucidate the molecular pathogenic mechanism of TAF15-associated neurodegenerative diseases, and will direct drug development targeting TAF15."], "CopyrightInformation": "Copyright \u00a9 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Chen", "ForeName": "Jialin", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China."}], "LastName": "Yuan", "ForeName": "Xiushuang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China."}], "LastName": "Wei", "ForeName": "Peng", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, China."}], "LastName": "Wang", "ForeName": "Daoping", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China."}], "LastName": "Chen", "ForeName": "Chen", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China."}], "LastName": "Guo", "ForeName": "Quanqiang", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Electronic address: luosz@mail.buct.edu.cn."}], "LastName": "Luo", "ForeName": "Shi-Zhong", "Initials": "SZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Electronic address: chenlong@mail.buct.edu.cn."}], "LastName": "Chen", "ForeName": "Long", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Biophys J", "NlmUniqueID": "0370626", "ISSNLinking": "0006-3495"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amyloid"}, {"RegistryNumber": "0", "NameOfSubstance": "Prion Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Prions"}, {"RegistryNumber": "0", "NameOfSubstance": "TAF15 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "TATA-Binding Protein Associated Factors"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amyloid"}, {"QualifierName": ["metabolism"], "DescriptorName": "Amyotrophic Lateral Sclerosis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Prion Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Prions"}, {"QualifierName": ["genetics"], "DescriptorName": "TATA-Binding Protein Associated Factors"}], "CoiStatement": "Declaration of interests The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ticozzi N., Vance C., et al. Landers J. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011;156:285\u2013290. doi: 10.1002/ajmg.b.31158.", "ArticleIdList": ["10.1002/ajmg.b.31158", "21438137"]}, {"Citation": "Li Y.Q., Tan M.S., et al. Tan L. Frontotemporal lobar degeneration: mechanisms and therapeutic strategies. Mol. Neurobiol. 2016;53:6091\u20136105. doi: 10.1007/s12035-015-9507-5.", "ArticleIdList": ["10.1007/s12035-015-9507-5", "26537902"]}, {"Citation": "Svetoni F., Frisone P., Paronetto M.P. Role of FET proteins in neurodegenerative disorders. RNA Biol. 2016;13:1089\u20131102. doi: 10.1080/15476286.2016.1211225.", "ArticleIdList": ["10.1080/15476286.2016.1211225", "PMC5100351", "27415968"]}, {"Citation": "Luo F., Gui X., et al. Liu C. Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol. 2018;25:341\u2013346. doi: 10.1038/s41594-018-0050-8.", "ArticleIdList": ["10.1038/s41594-018-0050-8", "29610493"]}, {"Citation": "Yang W., Dunlap J.R., et al. Wetzel R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 2002;11:2905\u20132917. doi: 10.1093/hmg/11.23.2905.", "ArticleIdList": ["10.1093/hmg/11.23.2905", "12393802"]}, {"Citation": "Chen S.M., Ferrone F.A., Wetzel R. Huntington\u2019s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. U\u00a0S\u00a0A. 2002;99:11884\u201311889. doi: 10.1073/pnas.182276099.", "ArticleIdList": ["10.1073/pnas.182276099", "PMC129363", "12186976"]}, {"Citation": "Scherzinger E., Sittler A., et al. Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. U\u00a0S\u00a0A. 1999;96:4604\u20134609. doi: 10.1073/pnas.96.8.4604.", "ArticleIdList": ["10.1073/pnas.96.8.4604", "PMC16379", "10200309"]}, {"Citation": "Kayed R., Head E., et al. Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486\u2013489. doi: 10.1126/science.1079469.", "ArticleIdList": ["10.1126/science.1079469", "12702875"]}, {"Citation": "Straub J.E., Thirumalai D. Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Annu. Rev. Phys. Chem. 2011;62:437\u2013463. doi: 10.1146/annurev-physchem-032210-103526.", "ArticleIdList": ["10.1146/annurev-physchem-032210-103526", "21219143"]}, {"Citation": "Ray S., Singh N., et al. Maji S.K. \u03b1-Synuclein aggregation nucleates through liquid\u2013liquid phase separation. Nat. Chem. 2020;12:705\u2013716. doi: 10.1038/s41557-020-0465-9.", "ArticleIdList": ["10.1038/s41557-020-0465-9", "32514159"]}, {"Citation": "Alberti S., Gladfelter A., Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell. 2019;176:419\u2013434. doi: 10.1016/j.cell.2018.12.035.", "ArticleIdList": ["10.1016/j.cell.2018.12.035", "PMC6445271", "30682370"]}, {"Citation": "Boyko S., Surewicz K., Surewicz W.K. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation. Proc. Natl. Acad. Sci. U\u00a0S\u00a0A. 2020;117:31882\u201331890. doi: 10.1073/pnas.2012460117.", "ArticleIdList": ["10.1073/pnas.2012460117", "PMC7749306", "33262278"]}, {"Citation": "Patel A., Lee H.O., et al. Alberti S. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066\u20131077. doi: 10.1016/j.cell.2015.07.047.", "ArticleIdList": ["10.1016/j.cell.2015.07.047", "26317470"]}, {"Citation": "Ding X., Sun F., et al. Luo S.Z. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J.\u00a0Mol. Biol. 2020;432:467\u2013483. doi: 10.1016/j.jmb.2019.11.017.", "ArticleIdList": ["10.1016/j.jmb.2019.11.017", "31805282"]}, {"Citation": "Conicella A.E., Zerze G.H., et al. Fawzi N.L. ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537\u20131549. doi: 10.1016/j.str.2016.07.007.", "ArticleIdList": ["10.1016/j.str.2016.07.007", "PMC5014597", "27545621"]}, {"Citation": "Molliex A., Temirov J., et al. Taylor J. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123\u2013133. doi: 10.1016/j.cell.2015.09.015.", "ArticleIdList": ["10.1016/j.cell.2015.09.015", "PMC5149108", "26406374"]}, {"Citation": "Pak C.W., Kosno M., et al. Rosen M. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol. Cell. 2016;63:72\u201385. doi: 10.1016/j.molcel.2016.05.042.", "ArticleIdList": ["10.1016/j.molcel.2016.05.042", "PMC4973464", "27392146"]}, {"Citation": "Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 2017;136:1193\u20131214. doi: 10.1007/s00439-017-1830-7.", "ArticleIdList": ["10.1007/s00439-017-1830-7", "PMC5602095", "28762175"]}, {"Citation": "Kwon I., Kato M., et al. McKnight S. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155:1049\u20131060. doi: 10.1016/j.cell.2013.10.033.", "ArticleIdList": ["10.1016/j.cell.2013.10.033", "PMC4010232", "24267890"]}, {"Citation": "Kapeli K., Pratt G.A., et al. Yeo G.W. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7:12143. doi: 10.1038/ncomms12143.", "ArticleIdList": ["10.1038/ncomms12143", "PMC4935974", "27378374"]}, {"Citation": "Neumann M., Bentmann E., et al. Mackenzie I.R.A. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595\u20132609. doi: 10.1093/brain/awr201.", "ArticleIdList": ["10.1093/brain/awr201", "PMC3170539", "21856723"]}, {"Citation": "Couthouis J., Hart M.P., et al. Gitler A.D. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:2899\u20132911. doi: 10.1093/hmg/dds116.", "ArticleIdList": ["10.1093/hmg/dds116", "PMC3373238", "22454397"]}, {"Citation": "Yang L., Gal J., et al. Zhu H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. U\u00a0S\u00a0A. 2014;111:17809\u201317814. doi: 10.1073/pnas.1414004111.", "ArticleIdList": ["10.1073/pnas.1414004111", "PMC4273402", "25453086"]}, {"Citation": "March Z.M., King O.D., Shorter J. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9\u201318. doi: 10.1016/j.brainres.2016.02.037.", "ArticleIdList": ["10.1016/j.brainres.2016.02.037", "PMC5003744", "26996412"]}, {"Citation": "Toombs J.A., McCarty B.R., Ross E.D. Compositional determinants of prion formation in yeast. Mol. Cell Biol. 2010;30:319\u2013332. doi: 10.1128/mcb.01140-09.", "ArticleIdList": ["10.1128/mcb.01140-09", "PMC2798286", "19884345"]}, {"Citation": "Ash P.E., Zhang Y.J., et al. Link C.D. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet. 2010;19:3206\u20133218. doi: 10.1093/hmg/ddq230.", "ArticleIdList": ["10.1093/hmg/ddq230", "PMC2908471", "20530643"]}, {"Citation": "Sun Z., Diaz Z., et al. Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.", "ArticleIdList": ["10.1371/journal.pbio.1000614", "PMC3082519", "21541367"]}, {"Citation": "Carballo-Pacheco M., Strodel B. Advances in the simulation of protein aggregation at the atomistic scale. J.\u00a0Phys. Chem. B. 2016;120:2991\u20132999. doi: 10.1021/acs.jpcb.6b00059.", "ArticleIdList": ["10.1021/acs.jpcb.6b00059", "26965454"]}, {"Citation": "Dror R.O., Dirks R.M., et al. Shaw D.E. Biomolecular simulation: a computational microscope for molecular biology. Annu. Rev. Biophys. 2012;41:429\u2013452. doi: 10.1146/annurev-biophys-042910-155245.", "ArticleIdList": ["10.1146/annurev-biophys-042910-155245", "22577825"]}, {"Citation": "Owen M.C., Gnutt D., et al. Strodel B. Effects of in\u00a0vivo conditions on amyloid aggregation. Chem. Soc. Rev. 2019;48:3946\u20133996. doi: 10.1039/c8cs00034d.", "ArticleIdList": ["10.1039/c8cs00034d", "31192324"]}, {"Citation": "Redler R.L., Shirvanyants D., et al. Dokholyan N.V. Computational approaches to understanding protein aggregation in neurodegeneration. J.\u00a0Mol. Cell Biol. 2014;6:104\u2013115. doi: 10.1093/jmcb/mju007.", "ArticleIdList": ["10.1093/jmcb/mju007", "PMC3995224", "24620031"]}, {"Citation": "Wei G., Mousseau N., Derreumaux P. Computational simulations of the early steps of protein aggregation. Prion. 2007;1:3\u20138. doi: 10.4161/pri.1.1.3969.", "ArticleIdList": ["10.4161/pri.1.1.3969", "PMC2633700", "19164927"]}, {"Citation": "Wen J., Scoles D.R., Facelli J.C. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments. PLoS One. 2017;12:e0178333. doi: 10.1371/journal.pone.0178333.", "ArticleIdList": ["10.1371/journal.pone.0178333", "PMC5444867", "28542401"]}, {"Citation": "Galm L., Amrhein S., Hubbuch J. Predictive approach for protein aggregation: correlation of protein surface characteristics and conformational flexibility to protein aggregation propensity. Biotechnol. Bioeng. 2017;114:1170\u20131183. doi: 10.1002/bit.25949.", "ArticleIdList": ["10.1002/bit.25949", "26853436"]}, {"Citation": "Grassmann G., Miotto M., et al. Milanetti E. A computational approach to investigate TDP-43 RNA-recognition motif 2 C-terminal fragments aggregation in amyotrophic lateral sclerosis. Biomolecules. 2021;11:1905. doi: 10.3390/biom11121905.", "ArticleIdList": ["10.3390/biom11121905", "PMC8699346", "34944548"]}, {"Citation": "Ng Y.K., Tajoddin N.N., et al. Konermann L. Mechanism of thermal protein aggregation: experiments and molecular dynamics simulations on the high-temperature behavior of myoglobin. J.\u00a0Phys. Chem. B. 2021;125:13099\u201313110. doi: 10.1021/acs.jpcb.1c07210.", "ArticleIdList": ["10.1021/acs.jpcb.1c07210", "34808050"]}, {"Citation": "King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61\u201380. doi: 10.1016/j.brainres.2012.01.016.", "ArticleIdList": ["10.1016/j.brainres.2012.01.016", "PMC3372647", "22445064"]}, {"Citation": "Couthouis J., Hart M.P., et al. Gitler A.D. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. U\u00a0S\u00a0A. 2011;108:20881\u201320890. doi: 10.1073/pnas.1109434108.", "ArticleIdList": ["10.1073/pnas.1109434108", "PMC3248518", "22065782"]}, {"Citation": "Modi V., Xu Q., et al. Dunbrack R.L., Jr. Assessment of template-based modeling of protein structure in CASP11. Proteins. 2016;84:200\u2013220. doi: 10.1002/prot.25049.", "ArticleIdList": ["10.1002/prot.25049", "PMC5030193", "27081927"]}, {"Citation": "Kryshtafovych A., Monastyrskyy B., et al. Tramontano A. Evaluation of the template-based modeling in CASP12. Proteins. 2018;86:321\u2013334. doi: 10.1002/prot.25425.", "ArticleIdList": ["10.1002/prot.25425", "PMC5877821", "29159950"]}, {"Citation": "Baker D., Sali A. Protein structure prediction and structural genomics. Science. 2001;294:93\u201396. doi: 10.1126/science.1065659.", "ArticleIdList": ["10.1126/science.1065659", "11588250"]}, {"Citation": "Harrison A.F., Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem.\u00a0J. 2017;474:1417\u20131438. doi: 10.1042/bcj20160499.", "ArticleIdList": ["10.1042/bcj20160499", "PMC5639257", "28389532"]}, {"Citation": "Abraham M.J., Murtola T., et al. Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19\u201325. doi: 10.1016/j.softx.2015.06.001.", "ArticleIdList": ["10.1016/j.softx.2015.06.001"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J.\u00a0Mol. Graph. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Lee J., Cheng X., et al. Im W. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J.\u00a0Chem. Theor. Comput. 2015;12:405\u2013413. doi: 10.1021/acs.jctc.5b00935.", "ArticleIdList": ["10.1021/acs.jctc.5b00935", "PMC4712441", "26631602"]}, {"Citation": "Jo S., Kim T., et al. Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J.\u00a0Comput. Chem. 2008;29:1859\u20131865. doi: 10.1002/jcc.20945.", "ArticleIdList": ["10.1002/jcc.20945", "18351591"]}, {"Citation": "Bekker H., van den Berg J.P., Wassenaar T.A. A method to obtain a near-minimal-volume molecular simulation of a macromolecule, using periodic boundary conditions and rotational constraints. J.\u00a0Comput. Chem. 2004;25:1037\u20131046. doi: 10.1002/jcc.20050.", "ArticleIdList": ["10.1002/jcc.20050", "15067679"]}, {"Citation": "Hess B. P-LINCS:\u2009 A parallel linear constraint solver for molecular simulation. J.\u00a0Chem. Theor. Comput. 2008;4:116\u2013122. doi: 10.1021/ct700200b.", "ArticleIdList": ["10.1021/ct700200b", "26619985"]}, {"Citation": "Kawata M., Nagashima U. Particle mesh Ewald method for three-dimensional systems with two-dimensional periodicity. Chem. Phys. Lett. 2001;340:165\u2013172. doi: 10.1016/s0009-2614(01)00393-1.", "ArticleIdList": ["10.1016/s0009-2614(01)00393-1"]}, {"Citation": "Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J.\u00a0Chem. Phys. 2007;126 doi: 10.1063/1.2408420.", "ArticleIdList": ["10.1063/1.2408420", "17212484"]}, {"Citation": "Carretero-Gonz\u00e1lez R., Kevrekidis P.G., et al. Frantzeskakis D.J. A Parrinello-Rahman approach to vortex lattices. Phys. Lett. 2005;341:128\u2013134. doi: 10.1016/j.physleta.2005.04.046.", "ArticleIdList": ["10.1016/j.physleta.2005.04.046"]}, {"Citation": "Saini A., Chauhan V.S. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment. Chembiochem. 2011;12:2495\u20132501. doi: 10.1002/cbic.201100427.", "ArticleIdList": ["10.1002/cbic.201100427", "21905193"]}, {"Citation": "Babinchak W.M., Haider R., et al. Surewicz W.K. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain. J.\u00a0Biol. Chem. 2019;294:6306\u20136317. doi: 10.1074/jbc.ra118.007222.", "ArticleIdList": ["10.1074/jbc.ra118.007222", "PMC6484124", "30814253"]}, {"Citation": "Wang K., Liu J.Q., et al. Liang Y. Phase separation and cytotoxicity of tau are modulated by protein disulfide isomerase and S-nitrosylation of this molecular chaperone. J.\u00a0Mol. Biol. 2020;432:2141\u20132163. doi: 10.1016/j.jmb.2020.02.013.", "ArticleIdList": ["10.1016/j.jmb.2020.02.013", "32087196"]}, {"Citation": "Monahan Z., Ryan V.H., et al. Fawzi N.L. Phosphorylation of\u00a0the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO\u00a0J. 2017;36:2951\u20132967. doi: 10.15252/embj.201696394.", "ArticleIdList": ["10.15252/embj.201696394", "PMC5641905", "28790177"]}, {"Citation": "Zhang Z., Chen H., et al. Lai L. Molecular dynamics simulations on the oligomer-formation process of the GNNQQNY peptide from yeast prion protein Sup35. Biophys.\u00a0J. 2007;93:1484\u20131492. doi: 10.1529/biophysj.106.100537.", "ArticleIdList": ["10.1529/biophysj.106.100537", "PMC1948036", "17483185"]}, {"Citation": "Yang J., Agnihotri M.V., et al. Singer S.J. A theoretical study of polymorphism in VQIVYK fibrils. Biophys.\u00a0J. 2021;120:1396\u20131416. doi: 10.1016/j.bpj.2021.01.032.", "ArticleIdList": ["10.1016/j.bpj.2021.01.032", "PMC8105716", "33571490"]}, {"Citation": "Alvarenga L.M., Machado de Avila R.A., et al. Ch\u00e1vez-Ol\u00f3rtegui C. Molecular characterization of a neutralizing murine monoclonal antibody against Tityus serrulatus scorpion venom. Toxicon. 2005;46:664\u2013671. doi: 10.1016/j.toxicon.2005.07.014.", "ArticleIdList": ["10.1016/j.toxicon.2005.07.014", "16168449"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "7"}, {"Year": "2022", "Month": "4", "Day": "28"}, {"Year": "2022", "Month": "5", "Day": "24"}, {"Year": "2022", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "1", "Hour": "9", "Minute": "37"}, {"Year": "2023", "Month": "7", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35643629", "PMC9300678", "10.1016/j.bpj.2022.05.038", "S0006-3495(22)00431-3"]}}], "PubmedBookArticle": []}